The establishment and evaluation of a new model for the prediction of prostate cancer

To develop a new prostate cancer predictor (PCP) model using the combination of total prostate-specific antigen (tPSA), free PSA (fPSA), and complexed PSA (cPSA). The diagnoses of all the included patients were confirmed pathologically in Daping Hospital between December 1, 2011 and December 1, 2014...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Li, Yan-Feng, Jiang, Jun, Zhang, Yong, Liu, Xu-Dong, Li, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369881/
https://www.ncbi.nlm.nih.gov/pubmed/28296726
http://dx.doi.org/10.1097/MD.0000000000006138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369881/
https://www.ncbi.nlm.nih.gov/pubmed/28296726
http://dx.doi.org/10.1097/MD.0000000000006138

Ejemplares similares